NCT04527718View on ClinicalTrials.gov

Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

August 13, 2021

Study Completion Date

August 13, 2021

Conditions
Healthy
Interventions
DRUG

Placebo

placebo as a single SC injection on Day 1;

DRUG

611

611 as a single SC injection on Day 1;

Trial Locations (1)

75247

Covance Dallas Clinical Research Unit, Dallas

All Listed Sponsors
lead

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

INDUSTRY

NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers | Biotech Hunter | Biotech Hunter